Asthma drug could halve chance of developing Parkinson’s

News

Author: Parkinson's Life editorsPublished: 28 September 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Asthma medication

A recent study has found that a drug most commonly used for asthma may cut the chances of developing Parkinson’s.

The research, carried out by Harvard Medical School, Massachusetts, US, found that those who inhaled salbutamol – a drug found in inhalers – were half as likely to develop the condition.

In Parkinson’s disease, a protein named a-synuclein accumulates in various brain cells and can be fatal. To counter this, the research team grew human nerve cells and tested over 1000 medications, finding results to suggest salbutamol could cut the production of a-synuclein.

Neurologist Anthony Lang, who works at the University of Toronto, Canada, said the results were “fascinating” and “had come out of the blue”.

Despite some encouraging developments, Clemens Scherzer, who was a part of the research team, said clinical trials were “a few years off”.

Go Back

Share this story

Comments


Related articles


A clinician and patient discuss medication.

Global update

Parkinson’s in the news: November

This month’s Parkinson’s disease stories from around the globe

READ MORE
National Parkinson Foundation

Carers' Corner

Learn coping tricks and strategies for carers at Parkinson’s summit

The Caregiver's Summit aims to equip carers with the tools to take charge

READ MORE
Man lifting weights

Global update

7 of our favourite Parkinson’s Life stories from 2022

Sharing voices from the global Parkinson’s disease community

READ MORE